NBN 657del5 heterozygous mutations and colorectal cancer risk in the Czech Republic

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 666, Issue 1-2, 2009, Pages 64-67

  Pardini, Barbara ^a   Naccarati, Alessio ^a   Polakova, Veronika ^a,b   Smerhovsky, Zdenek ^b   Hlavata, Ivona ^b,c   Soucek, Pavel ^c   Novotny, Jan ^b   Vodickova, Ludmila ^a,c   Tomanova, Vera ^d   Landi, Stefano ^e   Vodicka, Pavel ^a,b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^d Hospital Jihlava   (Czech Republic)

^e UNIVERSITY OF PISA   (Italy)

Author keywords

Colorectal cancer; NBN 657del5; NBS

Indexed keywords

NIBRIN;

ADULT; ARTICLE; BLOOD DONOR; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; CZECH REPUBLIC; FEMALE; GENE DELETION; GENETIC ASSOCIATION; HETEROZYGOSITY; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATION; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CELL CYCLE PROTEINS; COLORECTAL NEOPLASMS; CZECH REPUBLIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; NUCLEAR PROTEINS; SEQUENCE DELETION;

EID: 65749099418     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2009.04.004     Document Type: Article

References (29)

1. Van der Burgt I., Chrzanowska K.H., Smeets D., and Weemaes C. Nijmegen breakage syndrome. J. Med. Genet. 33 (1996) 153-156
2. Varon R., Vissinga C., Platzer M., Cerosaletti K.M., Chrzanowska K.H., Saar K., Beckmann G., Seemanova E., Cooper P.R., Nowak N.J., Stumm M., Weemaes C.M., Gatti R.A., Wilson R.K., Digweed M., Rosenthal A., Sperling K., Concannon P., and Reis A. Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 93 (1998) 467-476
3. Tauchi H., Matsuura S., Kobayashi J., Sakamoto S., and Komatsu K. Nijmegen breakage syndrome gene, NBS1, and molecular links to factors for genome stability. Oncogene 21 (2002) 8967-8980
4. Kracker S., Bergmann Y., Demuth I., Frappart P.O., Hildebrand G., Christine R., Wang Z.Q., Sperling K., Digweed M., and Radbruch A. Nibrin functions in Ig class-switch recombination. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 1584-1589
5. Digweed M., and Sperling K. Nijmegen breakage syndrome: clinical manifestation of defective response to DNA double-strand breaks. DNA Repair (Amst.) 3 (2004) 1207-1217
6. Seemanova E., Sperling K., Neitzel H., Varon R., Hadac J., Butova O., Schröck E., Seeman P., and Digweed M. Nijmegen breakage syndrome (NBS) with neurological abnormalities and without chromosomal instability. J. Med. Genet. 43 (2006) 218-224
7. Krüger L., Demuth I., Neitzel H., Varon R., Sperling K., Chrzanowska K.H., Seemanova E., and Digweed M. Cancer incidence in Nijmegen breakage syndrome is modulated by the amount of a variant NBS protein. Carcinogenesis 28 (2007) 107-111
8. Varon R., Seemanova E., Chrzanowska K., Hnateyko O., Piekutowska-Abramczuk D., Krajewska-Walasek M., Sykut-Cegielska J., Sperling K., and Reis A. Clinical ascertainment of Nijmegen breakage syndrome (NBS) and prevalence of the major mutation, 657del5, in three Slav populations. Eur. J. Hum. Genet. 8 (2000) 900-902
9. Dzikiewicz-Krawczyk A. The importance of making ends meet: mutations in genes and altered expression of proteins of the MRN complex and cancer. Mutat. Res. 659 (2008) 262-273
10. Seemanova E. An increased risk for malignant neoplasms in heterozygotes for a syndrome of microcephaly, normal intelligence, growth retardation, remarkable facies, immunodeficiency and chromosomal instability. Mutat. Res. 238 (1990) 321-324
11. Seemanova E., Jarolim P., Seeman P., Varon R., Digweed M., Swift M., and Sperling K. Cancer risk of heterozygotes with the NBN founder mutation. J. Natl. Cancer Inst. 99 (2007) 1875-1880
12. Zhao S., Weng Y.C., Yuan S.S., Lin Y.T., Hsu H.C., Lin S.C., Gerbino E., Song M.H., Zdzienicka M.Z., Gatti R.A., Shay J.W., Ziv Y., Shiloh Y., and Lee E.Y. Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products. Nature 405 (2000) 473-477
13. Su Y., and Swift M. Mortality rates among carriers of ataxia-telangiectasia mutant alleles. Ann. Intern. Med. 133 (2000) 770-778
14. Neubauer S., Arutyunyan R., Stumm M., Dörk T., Bendix R., Bremer M., Varon R., Sauer R., and Gebhart E. Radiosensitivity of ataxia telangiectasia and Nijmegen breakage syndrome homozygotes and heterozygotes as determined by three-color FISH chromosome painting. Radiat. Res. 157 (2002) 312-321
15. Chrzanowska K.H., Piekutowska-Abramczuk D., Popowska E., Gładkowska-Dura M., Małdyk J., Syczewska M., Krajewska-Walasek M., Goryluk-Kozakiewicz B., Bubała H., Gadomski A., Gaworczyk A., Kazanowska B., Kołtan A., Kuźmicz M., Luszawska-Kutrzeba T., Maciejka-Kapuścińska L., Stolarska M., Stefańska K., Sznurkowska K., Wakulińska A., Wieczorek M., Szczepański T., and Kowalczyk J. Carrier frequency of mutation 657del5 in the NBS1 gene in a population of Polish pediatric patients with sporadic lymphoid malignancies. Int. J. Cancer 118 (2006) 1269-1274
16. Bogdanova N., Feshchenko S., Schürmann P., Waltes R., Wieland B., Hillemanns P., Rogov Y.I., Dammann O., Bremer M., Karstens J.H., Sohn C., Varon R., and Dörk T. Nijmegen Breakage Syndrome mutations and risk of breast cancer. Int. J. Cancer 122 (2008) 802-806
17. Steffen J., Maneva G., Popławska L., Varon R., Mioduszewska O., and Sperling K. Increased risk of gastrointestinal lymphoma in carriers of the 657del5 NBS1 gene mutation. Int. J. Cancer 119 (2006) 2970-2973
18. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 55 (2005) 74-108
19. Landi D., Gemignani F., Naccarati A., Pardini B., Vodicka P., Vodickova L., Novotny J., Försti A., Hemminki K., Canzian F., and Landi S. Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis 29 (2008) 579-584
20. Pardini B., Naccarati A., Novotny J., Smerhovsky Z., Vodickova L., Polakova V., Hanova M., Slyskova J., Tulupova E., Kumar R., Bortlik M., Barale R., Hemminki K., and Vodicka P. DNA repair genetic polymorphisms and risk of colorectal cancer in the Czech Republic. Mutat. Res. 638 (2008) 146-153
21. Vasen H.F., Mecklin J.P., Khan P.M., and Lynch H.T. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis. Colon Rectum 34 (1991) 424-425
22. Vasen H.F., Watson P., Mecklin J.P., and Lynch H.T. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116 (1999) 1453-1456
23. Singh H., Turner D., Xue L., Targownik L.E., and Bernstein C.N. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA 295 (2006) 2366-2373
24. Steffen J., Varon R., Mosor M., Maneva G., Maurer M., Stumm M., Nowakowska D., Rubach M., Kosakowska E., Ruka W., Nowecki Z., Rutkowski P., Demkow T., Sadowska M., Bidziński M., Gawrychowski K., and Sperling K. Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland. Int. J. Cancer 111 (2004) 67-71
25. Soucek P., Gut I., Trneny M., Skovlund E., Grenaker Alnaes G., Kristensen T., Børresen-Dale A.L., and Kristensen V.N. Multiplex single-tube screening for mutations in the Nijmegen Breakage Syndrome (NBS1) gene in Hodgkin's and non-Hodgkin's lymphoma patients of Slavic origin. Eur. J. Hum. Genet. 11 (2003) 416-419
26. Roznowski K., Januszkiewicz-Lewandowska D., Mosor M., Pernak M., Litwiniuk M., and Nowak J. I171V germline mutation in the NBS1 gene significantly increases risk of breast cancer. Breast Cancer Res. Treat. 110 (2008) 343-348
27. Bogdanova N., Schürmann P., Waltes R., Feshchenko S., Zalutsky I.V., Bremer M., and Dörk T. NBS1 variant I171V and breast cancer risk. Breast Cancer Res. Treat. 112 (2008) 75-79
28. Goodman J.E., Mechanic L.E., Luke B.T., Ambs S., Chanock S., and Harris C.C. Exploring SNP-SNP interactions and colon cancer risk using polymorphism interaction analysis. Int. J. Cancer 118 (2006) 1790-1797
29. Naccarati A., Pardini B., Hemminki K., and Vodicka P. Sporadic colorectal cancer and individual susceptibility: a review of the association studies investigating the role of DNA repair genetic polymorphisms. Mutat. Res. 635 (2007) 118-145